Last reviewed · How we verify

NCT06141135: GETSET

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Recruiting now NA Last updated 26 August 2025
What this trial tests

NA trial testing Preimplantation genetic testing for aneuploidy (PGTA) in Infertility, Female in 240 participants. Currently enrolling.

Timeline
15 November 2023
Primary endpoint
15 November 2025
15 November 2026

Quick facts

Lead sponsorGenomic Prediction Inc.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment240
Start date15 November 2023
Primary completion15 November 2025
Estimated completion15 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Genomic Prediction Inc.

Who can join

Adults 35 to 40, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other Genomic Prediction Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06141135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing